Offerings // bioAffinity Technologies, Inc.

BIAF offering history

Every offering-related filing in bioAffinity Technologies, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 398 filings back to Jul 26, 2017.

Last executed offering
Nov 2, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Sep 3, 2026
S-3/A — capacity, not a sale
Executed, last 12 months
6
424B pricings + 8-K 3.02 sales
Registered, last 12 months
5
S-1/S-3/F-series registrations
DateFilingWhat it means
Nov 2, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 9, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 9, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 9, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 8, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 4, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 3, 2026S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Aug 27, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Aug 14, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 18, 2026424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 16, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jun 16, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 12, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
May 14, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 12, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 30, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 9, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 30, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 29, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 25, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Sep 24, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Sep 18, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 16, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 15, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Aug 29, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Aug 14, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 3, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 3, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 27, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 7, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
May 5, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
May 5, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 2, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 22, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 18, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 11, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Feb 27, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 25, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 25, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 9, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
BIAF offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BIAF workspace →
BIAF offering FAQ

When did BIAF last execute an offering?

Per SEC filings, bioAffinity Technologies, Inc.'s most recent priced offering document is a 424B5 filed 2026-11-02. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BIAF last announce or register an offering?

The most recent registration is a S-3/A filed 2026-09-03. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.